European cytokine network 2000-09-01

Prostaglandin B(2) delivers a co-stimulatory signal leading to T cell activation.

N Cattan, D Mary, A Peleraux, B Mari, C Aussel, B Rossi

Index: Eur. Cytokine Netw. 11(2) , 293-9, (2000)

Full Text: HTML

Abstract

Most of the data accumulated to date on the immunoregulatory effects of prostaglandins (PG) on T cell activation stem from the archetypal inhibitory effect of PGE(2). In this study we provide instead, the first evidence that exogenous PGB(2), a catabolic metabolite of PGE(2), synergizes with signals delivered by T cell receptor (TCR) engagement to induce interleukin-2 (IL-2) production and IL-2 receptor (IL-2R) alpha-expression in Jurkat cells. Accordingly, PGB(2) enhances the proliferation of anti-CD3-activated peripheral blood lymphocytes (PBL). In terms of cellular signaling, we present evidence that PGB(2) activates tyrosine kinase activities and efficiently increases c-fos mRNA expression and nuclear factor-kappa B (NF-kappa B) translocation to the nucleus. Owing to these features, PGB(2) appears as a new lipid mediator capable of delivering an ancillary signal leading to T lymphocyte activation.


Related Compounds

  • Prostaglandin B2

Related Articles:

Identification of prostamides, fatty acyl ethanolamines, and their biosynthetic precursors in rabbit cornea.

2015-08-01

[J. Lipid Res. 56 , 1419-33, (2015)]

Differences in the Neuroprotective Effect of Orally Administered Virgin Olive Oil (Olea europaea) Polyphenols Tyrosol and Hydroxytyrosol in Rats.

2015-07-01

[J. Agric. Food Chem. 63 , 5957-63, (2015)]

Cord blood mesenchymal stem cells suppress DC-T Cell proliferation via prostaglandin B2.

2014-07-15

[Stem Cells Dev. 23(14) , 1582-93, (2014)]

Ca2+ mobilization with leukotriene A4 and epoxytetraenes in human neutrophils.

1990-01-15

[Biochem. Pharmacol. 39(2) , 355-65, (1990)]

Simultaneous determination of prostaglandins (PG) E2, A2 and B2 and stability studies of PGE2 in pharmaceutical preparations by ion-pair reversed phase HPLC.

1989-01-01

[Pharm. Acta Helv. 64(2) , 45-50, (1989)]

More Articles...